{"article_id": "DDD_q3_2021.txt", "article": ["since last quarter , we completed the last of our divestitures , retiring our debt and stockpiling over $ 500 million of cash on the balance sheet .", "and by 2005 , we were working with surgeons to design and manufacture customized patient - specific surgical guides and instruments using 3d printing .", "of note , our healthcare business grew over 28 % in our most recent quarter and over 44 % on an organic basis , which is where we disregard the businesses that we have divested .", "our solid execution in the face of these challenges in the third quarter resulted in strong double - digit growth with revenues increasing by 15 % before adjusting for divestitures .", "when these adjustments are made , which is a much better reflection of our core business performance , revenues were up over 36 % versus 2020 and up over 20 % versus our pre-pandemic 2019 third quarter , a benchmark we consider very important .", "as jagtar will discuss shortly , in addition to the strong revenue performance , our ebitda climbed by over 125 % .", "for the third quarter , we reported revenue of $ 156.1 million , an increase of 14.6 % compared to the third quarter of 2020 .", "our organic revenue growth , which excludes divestitures completed in 2020 and 2021 , was 35.9 % in q3 2021 versus q3 2020 .", "our revenue in the third quarter 2021 was 21.2 % higher than pre-pandemic q3 2019 .", "we reported gaap net income of $ 2.34 per share in the third quarter of 2021 compared to a gaap loss of $ 0.61 in the third quarter of 2020 .", "for our non-gaap results , we reported non-gaap income of $ 0.08 per share in the third quarter of 2021 compared to a non-gaap loss of $ 0.03 per share in the third quarter of 2020 .", "healthcare grew 28.3 % year - over - year and decreased 7.8 % compared to the last quarter .", "adjusted for divestitures , healthcare revenue increased 44.5 % year - over - year as a result of strong demand for dental applications in both printers and materials .", "our industrial segment generated revenue growth of 4 % to $ 79.7 million compared to the same period last year and was flat to last quarter , reflecting the divestiture of the on - demand manufacturing parts business during the quarter .", "adjusted for divestitures , industrial revenue increased 28.1 % year - over - year and 2.1 % over the last quarter .", "we reported gross profit margin of 41.2 % in the third quarter of 2021 compared to 43.1 % in the third quarter of 2020 .", "non-gaap gross profit margin was 41.5 % compared to 43.2 % in the same period last year .", "if we exclude the impact of those divestitures , gross profit -- gross margins increased 80 basis points in the third quarter of 2021 compared to the same period last year , driven by 2020 cost actions and the higher revenue , which resulted in better capacity utilization .", "year - to - date , our non-gaap gross profit margin was 42.6 % and we expect full year gross profit margins to be between 41 % and 43 % .", "operating expenses for the quarter were $ 81.5 million on a gaap basis , a decrease of 35.4 % compared to the third quarter of 2020 .", "our non-gaap operating expenses in the third quarter were $ 54.1 million , a decrease -- an 8 % decrease from the third quarter of the prior year .", "compared to the second quarter of 2021 , non-gaap operating expenses decreased 2 % , primarily driven by lower r&d spend .", "adjusted ebitda , defined as non-gaap operating profit plus depreciation , was $ 16.3 million or 10.5 % of revenue compared to $ 7.2 million or 5.3 % of revenue in the third quarter 2020 .", "we are pleased to show $ 502.8 million of cash on the balance sheet , an increase of $ 418.4 million since the beginning of the year .", "during the quarter , we generated $ 20.7 million of cash from operations , marking the fourth straight quarter of positive cash from operations .", "now that we have demonstrated consistent profitability and cash generation and post - divestiture $ 0.5 billion of cash on hand , we are in a prime position to continue growing the company by taking a disciplined approach to invest organic and inorganic solutions that will solve customers ' complex needs , drive adoption of additive manufacturing and generate high margin recurring revenue streams .", "the cash considerations for these will total approximately $ 130 million , leaving roughly $ 370 million of cash .", "we had just announced results for the second quarter of 2020 that included negative operating cash flow of $ 21 million for the first half of that year , cash and cash equivalents on the balance sheet of only $ 64 million and $ 22 million of debt .", "we have generated over $ 60 million of operating cash this year for the third quarter and ended the quarter with over $ 500 million of cash and cash equivalents with no debt .", "we are 100 % focused on additive manufacturing and growing strongly in our core markets ."], "summary_gold": "compname posts q3 earnings per share of $ 2.34 .<q>q3 gaap earnings per share $ 2.34 .<q>q3 revenue rose 14.6 percent to $ 156.1 million .<q>q3 non -gaap earnings per share $ 0.08 .<q>on a non -gaap basis company expects 2021 gross profit margins to be between 41 % and 43 % .", "summary_pred": "adjusted for divestitures , healthcare revenue increased 44.5 % year - over - year as a result of strong demand for dental applications in both printers and materials .<q>our non-gaap operating expenses in the third quarter were $ 54.1 million , a decrease -- an 8 % decrease from the third quarter of the prior year .<q>we are 100 % focused on additive manufacturing and growing strongly in our core markets .<q>when these adjustments are made , which is a much better reflection of our core business performance , revenues were up over 36 % versus 2020 and up over 20 % versus our pre-pandemic 2019 third quarter , a benchmark we consider very important .<q>year - to - date , our non-gaap gross profit margin was 42.6 % and we expect full year gross profit margins to be between 41 % and 43 % .<q>as jagtar will discuss shortly , in addition to the strong revenue performance , our ebitda climbed by over 125 % .<q>we had just announced results for the second quarter of 2020 that included negative operating cash flow of $ 21 million for the first half of that year , cash and cash equivalents on the balance sheet of only $ 64 million and $ 22 million of debt .<q>our industrial segment generated revenue growth of 4 % to $ 79.7 million compared to the same period last year and was flat to last quarter , reflecting the divestiture of the on - demand manufacturing parts business during the quarter .<q>and by 2005 , we were working with surgeons to design and manufacture customized patient - specific surgical guides and instruments using 3d printing .<q>our organic revenue growth , which excludes divestitures completed in 2020 and 2021 , was 35.9 % in q3 2021 versus q3 2020 .<q>the cash considerations for these will total approximately $ 130 million , leaving roughly $ 370 million of cash .", "len_article": 30, "len_summary_gold": 5, "len_summary_pred": 11, "len_sent_scores": 30}